Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship

CM Curieses Andrés, JM Pérez de Lastra… - 2024 - digital.csic.es
This article provides an overview of the development, structure and activity of various metal
complexes with anti-cancer activity. Chemical researchers continue to work on the …

[HTML][HTML] Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship

CMC Andrés, JM Pérez de la Lastra… - International Journal of …, 2024 - mdpi.com
This article provides an overview of the development, structure and activity of various metal
complexes with anti-cancer activity. Chemical researchers continue to work on the …

[HTML][HTML] A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies

S Adhikari, P Nath, A Das, A Datta, N Baildya… - Biomedicine & …, 2024 - Elsevier
Research into cancer therapeutics has uncovered various potential medications based on
metal-containing scaffolds after the discovery and clinical applications of cisplatin as an anti …

Unconventional anticancer metallodrugs and strategies to improve their pharmacological profile

M Contel - Inorganics, 2019 - mdpi.com
For the past 41 years, metal-based drugs have been widely used for the treatment of cancer.
Cisplatin and follow-up drugs carboplatin (Paraplatin™) and oxaliplatin (Eloxatin™) have …

Metallodrugs in cancer therapy: past, present and new strategies

I Kostova - Frontiers in Chemistry, 2024 - frontiersin.org
Cancer diagnostics and therapy that include metal-based pharmaceuticals have improved
over the past decades. The therapeutic importance and application of metals and their …

“Good Fashion is Evolution, Not Revolution”-Methods to Enhance Existing Anticancer Medicines, Primarily with the Use of Transition Metal

M Guzowska, M Kalinowska… - Anti-Cancer Agents in …, 2018 - ingentaconnect.com
The constant search for successful cancer therapies lasts for decades. Apart from the huge
scientific effort and enormous sum of spent money, only a small amount of newly developed …

Recent advances of metal-based anticancer agents and their in vivo potential against various types of malignancies

P Nath, A Datta, S Adhikari - Handbook of animal models and its uses in …, 2022 - Springer
Metal-based complexes have tremendous capacity to interact with biological molecules and
modify their actions. Due to their ability to modify enzymatic action, metabolism and …

Antitumor metallodrugs that target proteins

MP Sullivan, HU Holtkamp, CG Hartinger - Met. Ions Life Sci, 2018 - degruyter.com
Anticancer platinum-based drugs are widely used in the treatment of a variety of tumorigenic
diseases. They have been identified to target DNA and thereby induce apoptosis in cancer …

Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives

T Lazarević, A Rilak, ŽD Bugarčić - European journal of medicinal chemistry, 2017 - Elsevier
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …

Metal complexes in cancer therapy–an update from drug design perspective

U Ndagi, N Mhlongo, ME Soliman - Drug design, development and …, 2017 - Taylor & Francis
In the past, metal-based compounds were widely used in the treatment of disease
conditions, but the lack of clear distinction between the therapeutic and toxic doses was a …